Growth Metrics

Wave Life Sciences (WVE) Share-based Compensation (2015 - 2026)

Wave Life Sciences posted quarterly Share-based Compensation of $9.1 million for Q1 2026, up 82.98% year-on-year from $5.0 million in Q1 2025, and up 23.27% on a QoQ basis from $7.4 million in Q4 2025.

Wave Life Sciences (WVE) has 12 years of Share-based Compensation data on file, last reported at $9.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 82.98% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $29.1 million (up 91.17% YoY), and the FY2025 full-year result was $25.0 million, up 90.04% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $9.1 million, up from $7.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $9.1 million in Q1 2026 and bottomed at $2.3 million in Q3 2023.
  • The 5-year median for Share-based Compensation is $3.5 million (2024), against an average of $4.4 million.
  • The widest annual swing landed in 2022, when Share-based Compensation soared 155.33%; it then slumped 65.34% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $2.9 million in 2022, then dropped by 19.09% to $2.4 million in 2023, then surged by 37.93% to $3.2 million in 2024, then surged by 126.63% to $7.4 million in 2025, then climbed by 23.27% to $9.1 million in 2026.
  • The last three Share-based Compensation figures came in at $9.1 million (Q1 2026), $7.4 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 892,057.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 305,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 70.15 Mn
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 9.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.06 Mn
Mar 31, 2026 9.06 Mn
Dec 31, 2025 7.35 Mn
Dec 31, 2025 7.35 Mn
Sep 30, 2025 6.47 Mn
Sep 30, 2025 6.47 Mn
Jun 30, 2025 6.20 Mn
Jun 30, 2025 6.20 Mn
Mar 31, 2025 4.95 Mn
Mar 31, 2025 4.95 Mn
Dec 31, 2024 3.24 Mn
Dec 31, 2024 3.24 Mn
Sep 30, 2024 3.53 Mn
Sep 30, 2024 3.53 Mn
Jun 30, 2024 3.49 Mn
Jun 30, 2024 3.49 Mn
Mar 31, 2024 2.88 Mn
Mar 31, 2024 2.88 Mn
Dec 31, 2023 2.35 Mn
Dec 31, 2023 2.35 Mn
Sep 30, 2023 2.28 Mn
Sep 30, 2023 2.28 Mn
Jun 30, 2023 2.41 Mn
Jun 30, 2023 2.41 Mn
Mar 31, 2023 2.75 Mn
Mar 31, 2023 2.75 Mn
Dec 31, 2022 2.91 Mn
Dec 31, 2022 2.91 Mn
Sep 30, 2022 3.37 Mn
Sep 30, 2022 3.37 Mn
Jun 30, 2022 6.95 Mn
Jun 30, 2022 6.95 Mn
Mar 31, 2022 3.97 Mn
Mar 31, 2022 3.97 Mn
Dec 31, 2021 3.73 Mn
Dec 31, 2021 3.73 Mn
Sep 30, 2021 5.90 Mn
Sep 30, 2021 5.90 Mn
Jun 30, 2021 2.72 Mn
Jun 30, 2021 2.72 Mn
Mar 31, 2021 4.06 Mn
Mar 31, 2021 4.06 Mn
Dec 31, 2020 3.22 Mn
Dec 31, 2020 3.22 Mn
Sep 30, 2020 3.28 Mn
Sep 30, 2020 3.28 Mn
Jun 30, 2020 3.79 Mn
Jun 30, 2020 3.79 Mn
Mar 31, 2020 4.00 Mn
Mar 31, 2020 4.00 Mn
Dec 31, 2019 4.99 Mn
Dec 31, 2019 4.99 Mn
Sep 30, 2019 5.02 Mn
Sep 30, 2019 5.02 Mn
Jun 30, 2019 5.16 Mn
Jun 30, 2019 5.16 Mn
Mar 31, 2019 4.35 Mn
Mar 31, 2019 4.35 Mn
Dec 31, 2018 4.01 Mn
Dec 31, 2018 4.01 Mn
Sep 30, 2018 3.61 Mn
Sep 30, 2018 3.61 Mn
Jun 30, 2018 3.55 Mn
Jun 30, 2018 3.55 Mn
Mar 31, 2018 4.43 Mn
Mar 31, 2018 4.43 Mn
Dec 31, 2017 3.18 Mn
Dec 31, 2017 3.18 Mn
Sep 30, 2017 3.00 Mn
Sep 30, 2017 3.00 Mn
Jun 30, 2017 2.97 Mn
Jun 30, 2017 2.97 Mn
Mar 31, 2017 3.00 Mn
Mar 31, 2017 3.00 Mn
Dec 31, 2016 2.53 Mn
Dec 31, 2016 2.53 Mn
Sep 30, 2016 2.18 Mn
Sep 30, 2016 2.18 Mn
Jun 30, 2016 1.27 Mn
Jun 30, 2016 1.27 Mn
Mar 31, 2016 866,000.00
Mar 31, 2016 866,000.00
Dec 31, 2015 814,000.00
Dec 31, 2015 814,000.00
Sep 30, 2015 718,000.00
Sep 30, 2015 718,000.00
Jun 30, 2015 646,000.00
Jun 30, 2015 646,000.00
Mar 31, 2015 900,000.00
Mar 31, 2015 900,000.00